Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
Go back to Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update| (NYSE: LCTX) | Delayed: 1.27 -0.01 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.28 | 52 Week High | $ | |||
| Open | $1.29 | 52 Week Low | $ | |||
| Day High | $1.31 | P/E | N/A | |||
| Day Low | $1.26 | EPS | $ | |||
| Volume | 1,018,885 | |||||
| (NYSE: LCTX) | Delayed: 1.27 -0.01 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.28 | 52 Week High | $ | |||
| Open | $1.29 | 52 Week Low | $ | |||
| Day High | $1.31 | P/E | N/A | |||
| Day Low | $1.26 | EPS | $ | |||
| Volume | 1,018,885 | |||||

